4211 No. 3 Road Richmond BC Canada V6X 2C3
(604)  285 9975
Opening Hours

Mon – Fri: 9:00 – 17:00

Introduction

Our Products introduction

We seek investment opportunities in start-ups and innovators in the: pharmaceutical; medical devices, sciences, and services, and nutrition industries.

services

NON-INVASIVE HEMO-DYNAMICS MONITOR

The world’s first non-invasive, non-calibration-required, Hemo-Dynamics Monitor, Learn More

services

CARE INSURANCE BROKER LTD

 

services

SMART SURGICAL GLOVE DONNING MACHINE

Our surgical glove donning machines are used in operating theatres and sterile medical environments throughout China,Learn More

services

Craft Beer From Vancouver

 

opening hours

Monday9:00 – 17:00
Tuesday9:00 – 17:00
wednesday9:00 – 17:00
thursday9:00 – 17:00
Friday9:00 – 17:00

OUR PRIORITIES

departments

Breakthrough medical equipment, pharmaceutical and nutraceutical technologies from North America

departments

Innovative medical processes and practices

departments

New solutions in public and private health management

Background introduction

North America is the world’s largest health market with numerous exceptional research institutions. Most of the companies in North American medical sector are small and medium-sized enterprises engaged in the research and development of innovative technologies, products and solutions. To succeed, these companies need investment and assistance to advance beyond the product development stage. Lipont Caus Capital can help North American companies succeed in North America and China. Located in Richmond, British Columbia, we provide one-stop service for pioneering entrepreneurs and enterprises. Through our Libang Group colleagues we can assist North American companies to develop, commercialize and sell their products into China.

Improved health care is a priority in China. The government continues to increase investment to ensure that the entire population enjoys basic medical and health services and encouraged social investment to improve service quality. The embrace of modern medical capabilities and institutional reform has created opportunities for private investment in the health industry and profoundly affected the market structure.

The health care market is huge, but under-developed. And, it is growing rapidly, driven by an aging population, urbanization, increasing personal wealth, changing expectations and growing government and private sector investment. It is projected by Statistica that in 2018 China will spend USD 800 billion on public health. Moreover, as reported by the Organization for Economic Cooperation and Development, at 5.6% of GNP, China’s annual health care expenditure is prudent and sustainable, and has capacity to grow further in the future.

We want to work with medical and health entrepreneurs with interests advanced medical technology, medical device manufacturing, and health policy and program reform. We provide equity investment, incubation and guidance, to create future leaders in the industry.

Scientific research strength

5

Five R&D bases

Production capacity

4

Four production bases

Series

5

Anaesthesia Meds, Medical Nutrition, AI in medical use, Instruments + Systems used in Day Surgery

News and blog

News

We actively seek Innovations and startups (I/O Teams) in the field of health (medicine, medical devices, health solutions, health products, medical services, etc.)

Read More

Partners

深圳艺融同创基金菅理有限公司

北京力邦医疗投资菅理有限公司

Lipont Pharmaceuticals Inc.

Lipont Place Canada

Book an Appointment

Need to talk with us?
Book a meeting now, using your computer or mobile device. It’s quick and easy. Our service time is Mon – Fri 9:00 – 17:00.

services

Our Location
4211 No.3 Road, Richmond BC
V6X 2C3, Canada
(+01) 604-285-9975